CBS 2019
CBSMD教育中心
中 文

Drug Coated Balloon

Abstract

Recommended Article

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis Survival After Coronary Revascularization With Paclitaxel-Coated Balloons

Review Article2018 Feb 22;8(2):e017231.

JOURNAL:BMJ Open. Article Link

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials

Cai JZ, Zhu YX, Wang XY et al. Keywords: drug-coated balloon; drug-eluting stents; in-stent restenosis; meta-analysis

FULL TEXT PDF